Status:
COMPLETED
The Use of GnRH Agonist Trigger in the Prevention of OHSS
Lead Sponsor:
University of Connecticut
Collaborating Sponsors:
Organon
Conditions:
Ovarian Hyperstimulation Syndrome
Eligibility:
FEMALE
20-39 years
Phase:
PHASE4
Brief Summary
To compare the incidence of ovarian hyperstimulation syndrome (OHSS) and implantation rate between high responder patients using Gonadotropin releasing GnRH) agonist or human chorionic gonadotropin (h...
Detailed Description
OHSS is an iatrogenic complication of controlled ovarian hyperstimulation, which in its severe form, may result in significant morbidity. Although, there have been significant advances in in-vitro fer...
Eligibility Criteria
Inclusion
- age 20-39
- normal early follicular phase serum FSH (≤10.0 IU/l)
- patients with either PCOS or PCOM undergoing their first cycle of IVF or patients with high response in a previous IVF cycle.
Exclusion
- Hypogonadotropic hypogonadism
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT00349258
Start Date
August 1 2004
End Date
May 1 2006
Last Update
July 6 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Advanced Reproductive Services, UCHC
Farmington, Connecticut, United States, 06032